MEASURABLE DISEASE

Clinical trials for MEASURABLE DISEASE explained in plain language.

Never miss a new study

Get alerted when new MEASURABLE DISEASE trials appear

Sign up with your email to follow new studies for MEASURABLE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug combo aims to stop Leukemia's return

Disease control Terminated

This study tested whether combining the drugs venetoclax with azacytidine or DA could prevent relapse in acute myeloid leukemia (AML) patients who still had small amounts of cancer cells after initial treatment. The goal was to see if this 'preemptive' treatment could keep patien…

Matched conditions: MEASURABLE DISEASE

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

MEASURABLE DISEASE

Get alerted when new MEASURABLE DISEASE trials appear

New drug combo aims to stop Leukemia's return